Pfizer CEO found guilty of misleading public
A UK regulatory body found Pfizer CEO Albert Bourla guilty of making misleading statements about his company’s vaccine.

Mike Campbell

February 6, 2023

A UK regulatory body found Pfizer CEO Albert Bourla guilty of making misleading statements about his company’s vaccine.

In December 2021, Bourla appeared on the BBC, where he promoted the vaccine to children under 12 before the UK regulatory authorities had even authorized it. 

“Immunising that age group in the UK and Europe would be a very good idea,” Bourla said.

“There is no doubt in my mind that the benefits, completely are in favour of [vaccinating 5 to 11 year olds in the UK and Europe],” he added.

Subsequently, a private company called UsForThem, which seeks to protect children’s rights, filed a complaint to the UK’s Prescription Medicines Code of Practice Authority (PMCPA).

In December 2022, PMCPA determined Bourla’s statements breached three codes of practice because they were unsubstantiated and unbalanced. 

  • 6.1 – “Information, claims and comparisons must be accurate, balanced, fair, objective and unambiguous…”
  • 6.2 – “Any information, claim or comparison must be capable of substantiation.”
  • 26.2 – “Information about prescription only medicines which is made available to the public either directly or indirectly must be factual and presented in a balanced way.”

Sanction-wise, Pfizer was given a slap on the wrist. The PMCPA gave Pfizer a document which essentially attempts to ensure the same violations don’t happen again. Additionally, PMCPA made Pfizer pay administration charges for the case review.

In a detailed Substack on the case, UsForThem alleges the sanctions were so small because the PMCPA is financially captured by Pfizer. 

“The PMCPA, the key UK regulator in this area, operates as a division of the Association of the British Pharmaceutical Industry, the UK industry’s trade body.” 

“It is therefore a regulator funded by, and which exists only by the will of, the companies whose behaviour it is charged with overseeing. Despite Pharma being one of the most lucrative and well-funded sectors of the business world, the largely self-regulatory system on which the industry has now for decades had the privilege to rely has been under-resourced and has become slow, meek and powerless.” 

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

The feds introduced Canada’s first ever vaccine compensation program in 2020, just before they coerced vaccines into Canadians by threatening their livelihoods, jobs, and EI. 

Mike Campbell

April 18, 2024

Trending News

A study published in the New England Journal of Medicine has shown that Paxlovid has little to no efficacy in treating COVID.

TCS Wire

April 8, 2024

Trending News

Dr. Pierre Kory states that “we are facing an emerging toll of illness and death in the young. We cannot shirk from asking what is causing it.” 

Mike Campbell

March 28, 2024

Trending News

British farmers have formed a massive convoy and taken to the streets, storming the gates of Westminster, London, and protesting before parliament.

Keean Bexte

March 25, 2024

Trending News

“We’re talking about sterility:” Smith takes a victory lap over her trans policy announcements after the UK’s health authority bans puberty blockers for minors.

Alexa Posa

March 15, 2024

Trending News

Mainstream media is finally catching up, calling so-called gender-affirming care “a medical scandal of the first order.”

Mike Campbell

March 14, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.